173 related articles for article (PubMed ID: 35265223)
21. Integrative bioinformatics analysis of a prognostic index and immunotherapeutic targets in renal cell carcinoma.
Tao H; Li Z; Mei Y; Li X; Lou H; Dong L; Zhou L
Int Immunopharmacol; 2020 Oct; 87():106832. PubMed ID: 32738597
[TBL] [Abstract][Full Text] [Related]
22. Differential expression and prognostic value of TLR4 in kidney renal clear cell carcinoma.
Hu Y; Gu Y; Song Y; Zhao Y; Wang J; Ma J; Sui F
Mol Cell Probes; 2024 Jun; 75():101959. PubMed ID: 38579915
[TBL] [Abstract][Full Text] [Related]
23. Mir-451 Correlates with Prognosis of Renal Cell Carcinoma Patients and Inhibits Cellular Proliferation of Renal Cell Carcinoma.
Zhu S; Huang Y; Su X
Med Sci Monit; 2016 Jan; 22():183-90. PubMed ID: 26779781
[TBL] [Abstract][Full Text] [Related]
24. Expression of Genes Involved in Porphyrin Biosynthesis Pathway in the Human Renal Cell Carcinoma.
da Rocha Filho HN; da Silva EC; Silva FR; Courrol LC; de Mesquita CH; Bellini MH
J Fluoresc; 2015 Sep; 25(5):1363-9. PubMed ID: 26245452
[TBL] [Abstract][Full Text] [Related]
25. The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi-omics study.
Xu F; Guan Y; Xue L; Zhang P; Li M; Gao M; Chong T
Cancer Med; 2021 Dec; 10(24):9078-9096. PubMed ID: 34761566
[TBL] [Abstract][Full Text] [Related]
26. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
Sanchez A; Furberg H; Kuo F; Vuong L; Ged Y; Patil S; Ostrovnaya I; Petruzella S; Reising A; Patel P; Mano R; Coleman J; Russo P; Liu CH; Dannenberg AJ; Chan TA; Motzer R; Voss MH; Hakimi AA
Lancet Oncol; 2020 Feb; 21(2):283-293. PubMed ID: 31870811
[TBL] [Abstract][Full Text] [Related]
27. ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma.
Gao J; Yang D; Xu H; Yang K; Ma J; Xia J; Pan X
Bioengineered; 2022 Feb; 13(2):2412-2429. PubMed ID: 35094638
[TBL] [Abstract][Full Text] [Related]
28. The impact of TNFSF14 on prognosis and immune microenvironment in clear cell renal cell carcinoma.
Xu F; Guan Y; Zhang P; Xue L; Yang X; Gao K; Chong T
Genes Genomics; 2020 Sep; 42(9):1055-1066. PubMed ID: 32725578
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of immunological profile based on CD8+ and FoxP3+ T lymphocytes in the peritumoral and intratumoral subsites for renal cell carcinoma.
Teke K; Yaprak Bayrak B; Yuksekkaya M; Uslubas AK; Kosem ME; Yilmaz H; Kara O; Dillioglugil O
Int Urol Nephrol; 2020 Dec; 52(12):2289-2299. PubMed ID: 32761342
[TBL] [Abstract][Full Text] [Related]
30. Gene expression-based immune infiltration analyses of renal cancer and their associations with survival outcome.
Chen L; Yin L; Qi Z; Li J; Wang X; Ma K; Liu X
BMC Cancer; 2021 May; 21(1):595. PubMed ID: 34030645
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
[TBL] [Abstract][Full Text] [Related]
32. PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma.
Netti GS; Lucarelli G; Spadaccino F; Castellano G; Gigante M; Divella C; Rocchetti MT; Rascio F; Mancini V; Stallone G; Carrieri G; Gesualdo L; Battaglia M; Ranieri E
Aging (Albany NY); 2020 Apr; 12(8):7585-7602. PubMed ID: 32345771
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell carcinoma.
Lv S; Tao L; Liao H; Huang Z; Lu Y
Funct Integr Genomics; 2023 Jun; 23(2):193. PubMed ID: 37264263
[TBL] [Abstract][Full Text] [Related]
34. ZNF668: a new diagnostic predictor of kidney renal clear cell carcinoma.
Wei C; Gao Y; Chen X; Zhao C; Li P
Anticancer Drugs; 2022 Jan; 33(1):e491-e499. PubMed ID: 34261923
[TBL] [Abstract][Full Text] [Related]
35. Immune Cell Infiltration and Identifying Genes of Prognostic Value in the Papillary Renal Cell Carcinoma Microenvironment by Bioinformatics Analysis.
Liu T; Zhang M; Sun D
Biomed Res Int; 2020; 2020():5019746. PubMed ID: 32775427
[TBL] [Abstract][Full Text] [Related]
36. Favorable prognostic influence of T-box transcription factor Eomesodermin in metastatic renal cell cancer patients.
Dielmann A; Letsch A; Nonnenmacher A; Miller K; Keilholz U; Busse A
Cancer Immunol Immunother; 2016 Feb; 65(2):181-92. PubMed ID: 26753694
[TBL] [Abstract][Full Text] [Related]
37. Clinical utility of keratin 14 expression measurement in reflecting the tumor properties and prognosis in patients with renal cell carcinoma: a study with long-term follow-up.
Wang S; Gao P; Wang X; Duan L; He X; Qu J
Int Urol Nephrol; 2024 Jun; 56(6):2045-2053. PubMed ID: 38206525
[TBL] [Abstract][Full Text] [Related]
38. Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma.
Li L; Chen X; Hao L; Chen Q; Liu H; Zhou Q
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32662515
[TBL] [Abstract][Full Text] [Related]
39. ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway.
Zhang G; Yu Z; Fu S; Lv C; Dong Q; Fu C; Kong C; Zeng Y
Cancer Gene Ther; 2019 Sep; 26(9-10):323-333. PubMed ID: 30459398
[TBL] [Abstract][Full Text] [Related]
40. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
